Reduced Vancomycin Susceptibility in Staphylococcus aureus; Laboratory Detection and Genomic Characterization
Elsherbini, E., Metwally, D., Kandil, A., Abdel-Hamid, S., Alqahtani, T. (2018). Reduced Vancomycin Susceptibility in Staphylococcus aureus; Laboratory Detection and Genomic Characterization. EKB Journal Management System, 27(2), 99-106. doi: 10.21608/ejmm.2018.285548
Eglal Abdel Salam Elsherbini; Dalia El Sayed Metwally; Ahmed W. Kandil; Sherif Abdel-Hamid; Talal Y. Alqahtani. "Reduced Vancomycin Susceptibility in Staphylococcus aureus; Laboratory Detection and Genomic Characterization". EKB Journal Management System, 27, 2, 2018, 99-106. doi: 10.21608/ejmm.2018.285548
Elsherbini, E., Metwally, D., Kandil, A., Abdel-Hamid, S., Alqahtani, T. (2018). 'Reduced Vancomycin Susceptibility in Staphylococcus aureus; Laboratory Detection and Genomic Characterization', EKB Journal Management System, 27(2), pp. 99-106. doi: 10.21608/ejmm.2018.285548
Elsherbini, E., Metwally, D., Kandil, A., Abdel-Hamid, S., Alqahtani, T. Reduced Vancomycin Susceptibility in Staphylococcus aureus; Laboratory Detection and Genomic Characterization. EKB Journal Management System, 2018; 27(2): 99-106. doi: 10.21608/ejmm.2018.285548

Reduced Vancomycin Susceptibility in Staphylococcus aureus; Laboratory Detection and Genomic Characterization

Egyptian Journal of Medical Microbiology
Volume 27, Issue 2, April 2018, Page 99-106  XML PDF (399.28 K)
Document Type: New and original researches in the field of Microbiology.
DOI: 10.21608/ejmm.2018.285548
View on SCiNiTO View on SCiNiTO
Authors
Eglal Abdel Salam Elsherbini1; Dalia El Sayed Metwally email 1; Ahmed W. Kandil2; Sherif Abdel-Hamid3; Talal Y. Alqahtani4
1Department of Microbiology, Medical Research Institute, Alexandria University, Egypt.
2Department of Orthopedic and Trauma Surgery, Faculty of Medicine, Alexandria University, Egypt.
3Department of Anesthesia, Medical Research Institute, Alexandria University, Egypt.
4Faculty of Applied Medical Sciences, University of Sanaa, Yemen
Abstract
Background: The emergence of resistance to methicillin resistant Staphylococcus aureus (S.aurus) (MRSA), followed by Vancomycin resistant S.aurus has turned the therapy of staphylococcal infections into a worldwide challenge. Three classes of vancomycin-resistance have emerged that differ in vancomycin susceptibility; vancomycin resistant S.aureus (VRSA), Vancomycin intermediate S.aureus (VISA) and heterogenous vancomycin-Intermediate S.aureus (hVISA). Objectives: The present study aimed to detect S.aureus with reduced susceptibility to vancomycin in different types of clinical samples and their genomic characterizations. Methodology: The study was carried out on 250 S.aureus isolates from different types of clinical samples collected from patients admitted to various departments in the Alexandria University Hospitals, Egypt from May 2014 to April 2015. Results: We detected 22 S.aureus isolates with reduced sensitivity to vancomycin out of the 250 S.aureus test isolates by PAP-AUC and agar dilution methods. Three of them were VISA and 19 were hVISA; mainly isolated from pyogenic infections. Molecular typing of VISA and hVISA exhibited dominance of agr group Type I. Conclusion: Strict infection control measures and antibiotic policy should be adopted to control the problem of VISA and hVISA.
Keywords
S.aureus; Heteroresistance; Vancomycin; MRSA; vanA gene; Agr locus
Statistics
Article View: 44
PDF Download: 31